Goat and sheep ovarian tissue cryopreservation: Effects on the morphology and development of primordial follicles and density of stromal cell

2010 ◽  
Vol 122 (1-2) ◽  
pp. 90-97 ◽  
Author(s):  
L.R. Faustino ◽  
R.R. Santos ◽  
C.M.G. Silva ◽  
L.C. Pinto ◽  
J.J.H. Celestino ◽  
...  
2004 ◽  
Vol 16 (2) ◽  
pp. 180
Author(s):  
E. Papasso Brambilla ◽  
A. Paffoni ◽  
T.A.L. Brevini ◽  
M. De Eguileor ◽  
G. Ragni ◽  
...  

Ovarian tissue cryopreservation is of interest for many areas of assisted reproduction. Normal structure and intra- as well as intercellular organization have to be maintained in order to preserve follicle viability. In the present work we studied the effects of two largely used cryoprotectants, namely, dimethylsulphoxide (DMSO) and 1,2-propanediol (PROH), on follicle morphology. Experiments were carried out on bovine and porcine ovaries and the two cryoprotectants were assessed for their ability to preserve structural integrity of primordial, primary and secondary follicles, in order to investigate the protective effects of these molecules on specific developmental stages. Fragments from each ovary were divided in three groups: a) immediately fixed (control); b) cryopreserved in 1.5M DMSO; c) cryopreserved in 1.5M PROH. To allow equilibration with the cryoprotectant, samples were held for 30min at 4°C in order to minimize toxic effects. Cryopreservation was carried out in a controlled rate freezer (Planer Planerple, Sunbury, Middlesex, UK), with the following protocol: precooling (4°C); cooling at −2°C/min to 9°C; seeding at 9°C and standby for 10 minutes; cooling at −0.3°C/min to 40°C and 10°C/min to 140°C; plunging into liquid nitrogen. Samples were rapidly thawed. Dilution of cryoprotectants was carried out in 3 steps of ten minutes each at 4°C (1M; 0.5M; 0M). Samples were then fixed, paraffin embedded, serially sectioned and evaluated with a Nikon TE200 inverted microscope. Follicles of each developemental stage were scored in three categories using the criteria previously described by Paynter et al. (1999, Cryobiology 38, 301–309) and presented in the table below as I=Intact; SA=Small Abnormalities; GA=Great Abnormalities. Statistical differences were assessed by the chi-square test (P<0.05). The results obtained showed that both cryoprotectants are effective for the preservation of secondary follicles. The use of PROH was unable to protect primary and primordial follicles in both species. Conversely, DMSO showed a satisfying cryoprotecting effect for pig primary and bovine primordial follicles but had a poor protecting capability for pig primordial and bovine primary follicles. Altogether the present results suggest that the choice of the cryoprotectant needs to be carefully targeted in relation to the follicular stage and the species of interest. This work was funded by Industria Farmaceutica Serono SpA. Table 1


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
M Grellet-Grün ◽  
B Delepine ◽  
P Le Van Quyen ◽  
A Durlach ◽  
C Greze ◽  
...  

Abstract Study question What is the outcome of ovarian tissue cryopreservation (OTC) in paediatric patients from the beginning of its setting in two different French centres? Summary answer In our cohort of 75 paediatric patients who underwent OTC, the mean age, malignancy rate and survival rate were 9.7 years, 70.7% and 77.3% respectively. What is known already Cancer treatments of last decades improve the survival rate of children and adolescents; however chemo- and radiotherapy result in gonadal damage leading to acute ovarian failure and sterility. The preservation of fertility is now an integral part of care of children requiring gonadotoxic treatments. Currently OTC represents the only possibility of preserving the potential fertility in prepubertal girls. OTC is an effective fertility preservation option which allows long-term storage of primordial follicles, subsequent transplantation restores endocrine function and fertility. The efficacy of these techniques is well-demonstrated within adult population but the data are poor for paediatric patients. Study design, size, duration This is a retrospective study of OTC practice of two French centres from January 2004 to May 2020. Participants/materials, setting, methods A total of 75 patients from paediatrics units underwent cryopreservation of ovarian tissue before gonadotoxic therapy for malignant or benign diseases. The ovarian cortex was cut into fragments and the number of follicles per square millimeter was evaluated histologically. The long-term follow-up includes survival rate, hormonal and fertility status. Main results and the role of chance The mean age at OTC of 75 patients was 9.7 years [0.2 – 20], 32% were postpubertal. 53 had malignant disease and 22 had non-malignant disease. The most frequent diagnoses in this cohort included acute leukemia, hemoglobinopathies and neuroblastoma. Indication for OTC was stem cell transplantation for 78.7% (n = 59) girls. A third of each ovary was collected for 62,7% (n = 47) patients, a whole ovary for 33,3% (n = 25) patients and a third of one ovary alone for 4,0% (n = 3) patients. An average of 17 fragments [5-35] per patient was cryoconserved. A correlation was found between age and the number of fragments (p < 0.001). More fragments were obtained from partial bilateral harvesting than from whole ovary harvesting (p < 0.05). Histological analysis of ovarian tissue showed a median of 6.0 primordial follicles/mm2 [0.0–106.5] and no malignant cells were identified. A negative correlation was found between age and follicular density (p < 0.001). Median post-harvest follow-up was 92 months [1–188] 17 girls had died, 12 were still treated for their pathology and 46 were in complete remission. Of all patients, 29 have been subject to hormonal status evaluation and 26 were diagnosed with premature ovarian insufficiency (p < 0.001). One patient had undergone thawed ovarian tissue transplantation. Limitations, reasons for caution This study is a retrospective analysis. The cohort was not compared with a control group who did not undergo OTC or with an adult population. Furthermore, many of these girls are still young and do not intend to use the transplantation of thawed ovarian tissue yet. Wider implications of the findings OTC should be proposed to all girls with high risk of developing premature ovarian insufficiency following gonadotoxic therapies in order to give them the possibility of fertility and endocrine restoration. Trial registration number Not applicable


2021 ◽  
Vol 22 (5) ◽  
pp. 2534
Author(s):  
Sanghoon Lee ◽  
Hyun-Woong Cho ◽  
Boram Kim ◽  
Jae Kwan Lee ◽  
Tak Kim

The purpose of this study is to investigate the effectiveness of sphingosine-1-phosphate (S1P) and Z-VAD-FMK (Z-VAD) as anti-apoptotic agents to preserve ovarian function and prevent tissue damage during ovarian tissue cryopreservation and transplantation. This study consisted of two steps, in vitro and in vivo. In the first step, human ovarian tissues were cryopreserved using slow-freezing media alone, S1P, or Z-VAD (control, S1P, Z-VAD group); based on the outcomes in these groups, Z-VAD was selected for subsequent xenotransplantation. In the second step, human frozen/thawed ovarian tissues were grafted into fifty mice divided into three groups: slow-freezing/thawing and transplantation without an anti-apoptotic agent (Trans-control) and xenotransplantation with or without Z-VAD injection (Trans-Z-VAD-positive and Trams-Z-VAD-negative groups, respectively). In the first step, the Z-VAD group had a significantly higher primordial follicular count than the S1P (p = 0.005) and control groups (p = 0.04). Transplanted ovarian tissues were obtained 4 weeks after transplantation (second step). Angiogenesis was significantly increased in the Z-VAD-negative (p = 0.03) and -positive (p = 0.04) groups compared to the control group. This study demonstrated that slow-freezing and transplantation with Z-VAD is an effective method for preserving primordial follicle counts, decreasing double-strand DNA breaks, and increasing angiogenesis in a mouse model. Further molecular and clinical studies are needed to confirm these results.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
M Grellet-Grün ◽  
B Delepine ◽  
P L Va. Quyen ◽  
A Durlach ◽  
C Greze ◽  
...  

Abstract Study question What is the outcome of ovarian tissue cryopreservation (OTC) in paediatric patients from the beginning of its setting in two different French centres? Summary answer In our cohort of 75 paediatric patients who underwent OTC, the mean age, malignancy rate and survival rate were 9.7 years, 70.7% and 77.3% respectively. What is known already Cancer treatments of last decades improve the survival rate of children and adolescents; however chemo- and radiotherapy result in gonadal damage leading to acute ovarian failure and sterility. The preservation of fertility is now an integral part of care of children requiring gonadotoxic treatments. Currently OTC represents the only possibility of preserving the potential fertility in prepubertal girls. OTC is an effective fertility preservation option which allows long-term storage of primordial follicles, subsequent transplantation restores endocrine function and fertility. The efficacy of these techniques is well-demonstrated within adult population but the data are poor for paediatric patients. Study design, size, duration This is a retrospective study of OTC practice of two French centres from January 2004 to May 2020. Participants/materials, setting, methods A total of 75 patients from paediatrics units underwent cryopreservation of ovarian tissue before gonadotoxic therapy for malignant or benign diseases. The ovarian cortex was cut into fragments and the number of follicles per square millimeter was evaluated histologically. The long-term follow-up includes survival rate, hormonal and fertility status. Main results and the role of chance The mean age at OTC of 75 patients was 9.7 years [0.2 – 20], 32% were postpubertal. 53 had malignant disease and 22 had non-malignant disease. The most frequent diagnoses in this cohort included acute leukemia, hemoglobinopathies and neuroblastoma. Indication for OTC was stem cell transplantation for 78.7% (n = 59) girls. A third of each ovary was collected for 62,7% (n = 47) patients, a whole ovary for 33,3% (n = 25) patients and a third of one ovary alone for 4,0% (n = 3) patients. An average of 17 fragments [5–35] per patient was cryoconserved. A correlation was found between age and the number of fragments (p < 0.001). More fragments were obtained from partial bilateral harvesting than from whole ovary harvesting (p < 0.05). Histological analysis of ovarian tissue showed a median of 6.0 primordial follicles/mm2 [0.0–106.5] and no malignant cells were identified. A negative correlation was found between age and follicular density (p < 0.001). Median post-harvest follow-up was 92 months [1–188]: 17 girls had died, 12 were still treated for their pathology and 46 were in complete remission. Of all patients, 29 have been subject to hormonal status evaluation and 26 were diagnosed with premature ovarian insufficiency (p < 0.001). One patient had undergone thawed ovarian tissue transplantation. Limitations, reasons for caution This study is a retrospective analysis. The cohort was not compared with a control group who did not undergo OTC or with an adult population. Furthermore, many of these girls are still young and do not intend to use the transplantation of thawed ovarian tissue yet. Wider implications of the findings: OTC should be proposed to all girls with high risk of developing premature ovarian insufficiency following gonadotoxic therapies in order to give them the possibility of fertility and endocrine restoration. Trial registration number Not applicable


Reproduction ◽  
2008 ◽  
Vol 136 (6) ◽  
pp. 681-689 ◽  
Author(s):  
R A Anderson ◽  
W H B Wallace ◽  
D T Baird

Female fertility preservation provides significantly different challenges to that for the male, with the only established method being cryopreservation of embryos thus necessitating the involvement of a male. Other, experimental, options include oocyte or ovarian tissue cryopreservation. The latter has been regarded as a potential method for more than a decade, but has resulted in the birth of only five babies. It is not possible to be certain how many women have had ovarian tissue cryopreserved. Oocyte cryopreservation also remains experimental, but ∼100-fold more babies have been born through this technique over the last two decades. Ovarian tissue cryopreservation has the potential advantages of preservation of a large number of oocytes within primordial follicles, it does not require hormonal stimulation when time is short and indeed may be appropriate for the pre-pubertal. Disadvantages include the need for an invasive procedure, and the uncertain risk of ovarian contamination in haematological and other malignancies. We here review this approach in the context of our own experience of 36 women, highlighting issues of patient selection especially in the young, and uncertainties over the effects of cancer treatments on subsequent fertility. Of these 36 women, 11 have died but 5 have had spontaneous pregnancies. So far, none have requested reimplantation of their stored ovarian tissue. Ovarian cryopreservation appears to be a potentially valuable method for fertility preservation, but the indications and approaches best used remain unclear.


2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Li-fan Peng

Abstract Background With the growth of women’s age, ovarian failure can be caused by various factors. For the women who need chemotherapy because of cancer factors, the preservation of fertility is more urgent. The treatment of cancer is also a process in which all tissues and organs of the body are severely damaged, especially in the reproductive system. Main body As a new fertility preservation technology, autologous ovarian tissue cryopreservation and transplantation is developing rapidly and showing great potentiality in preserving ovarian endocrine function of young cervical cancer patients. Vitrification and slow freezing are two common techniques applied for ovarian tissue cryopreservation. Thus, cryopreserved/thawed ovarian tissue and transplantation act as an important method to preserve ovarian function during radiotherapy and chemotherapy, and ovarian cryopreservation by vitrification is a very effective and extensively used method to cryopreserve ovaries. The morphology of oocytes and granulosa cells and the structure of organelles were observed under the microscope of histology; the hormone content in the stratified culture medium of granulosa cells with the diameter of follicle was used to evaluate the development potential of ovarian tissue, and finally the ovarian tissue stimulation was determined by the technique of ovarian tissue transplantation. Conclusions Although there are some limitations, the team members still carry out this review to provide some references and suggestions for clinical decision-making and further clinical research.


Sign in / Sign up

Export Citation Format

Share Document